Similarly, in neurodegenerative diseases such as AD and PD, activating the JAK/STAT pathway by ADAM17-mediated shedding of cytokine receptors contributes to neuroinflammation and neuronal dysfunction [144]. This evidence concerns the gene ADAM17 and Parkinson disease.